VT News

Richard Odada

Ask VT AI
View News Summary
  • Generac's Q3 earnings miss and reduced 2025 sales and margin guidance send shares tumbling, despite long-term growth drivers remaining intact.
  • FDA proposes new guidelines to expedite biosimilar drug approvals, aiming to increase competition, lower prices, and improve patient access to biologic treatments.
  • Mercedes' Q3 profit drops 31% after €1.3bn restructuring, as it faces headwinds from US tariffs, rising costs, and the EV transition.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Generac's Q3 earnings miss and reduced 2025 sales and margin guidance send shares tumbling, despite long-term growth drivers remaining intact.
  • FDA proposes new guidelines to expedite biosimilar drug approvals, aiming to increase competition, lower prices, and improve patient access to biologic treatments.
  • Mercedes' Q3 profit drops 31% after €1.3bn restructuring, as it faces headwinds from US tariffs, rising costs, and the EV transition.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Richard Odada

Top Topics

Trending in U.S.

World

Sport